Results 141 to 150 of about 84,117 (291)

Carcinoembryonic Antigen and Smoking

open access: yesJournal of the Royal College of Physicians of London, 1982
C A, Clarke   +2 more
openaire   +2 more sources

Head‐to‐head comparison of the diagnostic value of fecal and serum carcinoembryonic antigen for colorectal cancer detection

open access: yesInternational Journal of Cancer, Volume 159, Issue 2, Page 516-525, 15 July 2026.
What's new? The diagnostic value of fecal versus serum carcinoembryonic antigen (CEA) for colorectal cancer detection remains unclear. This study provides a head‐to‐head comparison of serum and fecal CEA using matched samples from two large colorectal cancer screening studies and two fecal sample processing methods.
Xianzhe Li   +10 more
wiley   +1 more source

Pancreatic cysts suspected to be branch duct intraductal papillary mucinous neoplasm without concerning features have low risk for development of pancreatic cancer. [PDF]

open access: yes, 2015
BackgroundThe risk of developing pancreatic cancer is uncertain in patients with clinically suspected branch duct intraductal papillary mucinous neoplasm (BD-IPMN) based on the "high-risk stigmata" or "worrisome features" criteria proposed in the 2012 ...
Fehmi, Syed A   +9 more
core   +1 more source

Clinical Insights From a Case of Sifrim‐Hitz‐Weiss Syndrome With a CHD4 Variant: Expanding the Phenotypic Spectrum and Its Response to Growth Hormone Therapy

open access: yesAmerican Journal of Medical Genetics Part A, Volume 200, Issue 6, Page 1403-1410, June 2026.
ABSTRACT To enhance clinicians' understanding of Sifrim‐Hitz‐Weiss syndrome (SIHIWES), this study investigated the clinical phenotypes, genetic characteristics, and response to growth hormone therapy in a patient. A case of a patient with global developmental delay and distinctive facial features is presented.
Jianmei Zhang   +6 more
wiley   +1 more source

Combining mammaglobin and carcinoembryonic mRNA markers for early detection of micrometastases from breast cancers - a molecular study of 59 patients [PDF]

open access: yes, 2006
Introduction: As many as 30% of node-negative breast cancer patients relapse within five years, suggesting that current histological detection methods are inadequate for identifying metastatic disease. Detecting small number of cancer cells in the breast
Dastan, J.   +8 more
core  

Carcinoembryonic Antigen and Smoking

open access: yesJournal of the Royal College of Physicians of London, 1980
C, Clarke   +4 more
openaire   +2 more sources

Does Everyone Need CEA? A Case for Selective Omission After Colorectal Cancer Resection

open access: yes
ANZ Journal of Surgery, EarlyView.
Matthew P. Irwin   +3 more
wiley   +1 more source

Pancreatic Adenocarcinoma: Diagnosis by Ultrasound‐Guided Fine‐Needle Aspiration—Cyto‐Histological Correlation and Experience at a Multidisciplinary Tertiary Reference Center

open access: yesDiagnostic Cytopathology, Volume 54, Issue 6, Page 403-416, June 2026.
ABSTRACT Background Pancreatic adenocarcinoma (PDAC) is characterized by its poor prognosis. Cytology is essential for diagnostic confirmation and ancillary studies. The endoscopic ultrasound (EUS) set a precedent, facilitating cytological sampling through fine‐needle aspiration (FNA), with a sensitivity of 93% and a specificity of 95%.
Judith González‐López   +10 more
wiley   +1 more source

Tumor marker for colorectal cancer

open access: yesJournal of Health Science and Medical Research (JHSMR), 2010
Carcinoembryonic antigen (CEA) and Cancer antigen 19-9 (CA19-9) are the two most common tumor markers for colorectal cancer that are currently utilized clinically for investigation.
Sopon Jutiamornlert   +1 more
doaj  

Regulation of Immune Checkpoints: From Molecular Mechanisms to Clinical Therapies

open access: yesMedComm, Volume 7, Issue 6, June 2026.
Immune checkpoint inhibitors (ICIs) have revolutionized cancer treatment by unleashing antitumor immunity. This review comprehensively examines the molecular mechanisms underlying key immune checkpoints—including PD‐1/PD‐L1, CTLA‐4, and TIM‐3—and their clinical applications.
Qintao Ge   +9 more
wiley   +1 more source

Home - About - Disclaimer - Privacy